The Immunex Alumni: Where Are They Now?

Demi Allen, vice president law & compliance, ZymoGenetics

Mike Ambielli, biotechnology professional

Cathy Keck Anderson, deputy director of policy & communications, Bayer Healthcare

Noreen Andrews, computer system validation

Juli Ashburn, senior field force automation administrator, ZymoGenetics

Anne Aumell, donor relations officer, PATH

Agnieszka Bain, quality assurance specialist, Gilead Sciences

Tim Bair, senior manager, clinical manufacturing, Dendreon

Carol Barone, board member, Sustainable Path Foundation, project manager, quality assurance SNBL USA

Dauphine Barone, director of project management, Alder Biopharmaceuticals

Peter Baum, board member, Sustainable Path Foundation

Dan Becker, principal IS architect, Amgen

Patricia Beckmann, president and executive director, Oregon Translational Research and Drug Development Initiative

Courtney Beers, scientist, Amgen

Jean Berry, director of human resources, Allrecipes.com

Betty Bickford, quality assurance manager, Alder Biopharmaceuticals

Craig Biggs, associate director, medical information, Dendreon

Paige Billings, director of corporate training and leadership development, OSI Pharmaceuticals

Bryan Bischel, director of medical and regulatory affairs, Eyetech

Roy Black, scientist, Amgen [Added: 3:30 pm, 1/7/11]

Hal Blumberg, principal scientist, Novo Nordisk

Lisa Bockelie, developer, Bayer Corporate Business Services

Dwight Bolton, contract manufacturing manager, ZymoGenetics

Wendy Bones, technical writer, Dendreon

Mark Booth, chief commercial officer, Orexigen Therapeutics

Luis Borges, scientific director, Amgen

Ken Brasel, scientist II, Dendreon

Lisa Brown, director of information systems, Amgen

Jennifer Campanile, data center hardware facilities planner, IBM @Amgen [Added: 4:40 pm, 1/4/11]

Linda Carlock, scientist, toxicology, Amgen

Kim Carlson, content publisher, Microsoft

Katie Carrigan, director of human resources, ZymoGenetics

Kent Carter, medical science liaison, GTx Pharmaceuticals

Paul Carter, staff scientist and senior director of antibody engineering, Genentech

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.